https://www.techtransfer.nih.gov/kudo/avelumab-new-therapy-for-metastatic-merkel-cell-and-urothelial-carcinomas-0
Avelumab, New Therapy for Metastatic Merkel Cell and Urothelial Carcinomas | Technology Transfer
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01969
Avelumab and Stereotactic Body Radiation Therapy in Treating Patients with Non-responsive or...
Avelumab and Stereotactic Body Radiation Therapy in Treating Patients with Non-responsive or Progressive Metastatic Non-small Cell Lung Cancer Previously...
https://www.techtransfer.nih.gov/kudo/avelumab-new-therapy-for-metastatic-merkel-cell-and-urothelial-carcinomas
Avelumab, New Therapy for Metastatic Merkel Cell and Urothelial Carcinomas | Technology Transfer
https://pubmed.ncbi.nlm.nih.gov/34221958/
Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient...
This case report shows, for the first time, a patient experiencing a complete response after one dose of avelumab following extensive disease progression with...
https://www.mdpi.com/2218-0532/92/4/62
Avelumab in First Line Maintenance in Advanced Urothelial Carcinoma (aUC) in Elderly Patients:...
(1) Background Immune checkpoint inhibitors (ICIs) have recently become an important therapeutic option for patients with advanced urothelial carcinoma (aUC)....
first lineurothelial carcinomaavelumabmaintenance
https://pubmed.ncbi.nlm.nih.gov/37071838/?dopt=Abstract
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder...
https://adisinsight.springer.com/drugsafety/803929937?error=cookies_not_supported&code=54748cec-0bbb-4c89-965f-a0491b5241ce
Avelumab precautions revision to include severe skin disorders - AdisInsight
The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has published a notification for Revision of PRECAUTIONS issued by the Ministry of Health, Labour
skin disordersavelumabprecautionsrevisioninclude
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1465213/full
Frontiers | Case report: Radical robotic nephroureterectomy after chemotherapy followed by avelumab...
IntroductionPlatinum-based chemotherapy followed by the immune checkpoint inhibitor avelumab represents an intensified upfront therapy regimen that may resul...
case reportfollowed byfrontiersradicalrobotic
https://www.pfizer.com/science/clinical-trials/plain-language-study-results-summaries/study-avelumab-axitinib-versus
A study of Avelumab with Axitinib Versus Sunitinib in Advanced Renal Cell Cancer (JAVELIN Renal...